Telix Pharmaceuticals and CellSight Technologies Conclude Collaboration and License Agreement for VisAcT ImmunoPET Technology
19 sept. 2017 21h46 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and SAN FRANCISCO, Sept. 19, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (Telix, the Company) is pleased to announce the conclusion of a collaboration and licensing...
Kevin McCann and Mark Nelson Appointed to the Board of Directors of Telix Pharmaceuticals Limited
17 sept. 2017 18h00 HE
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have been...